LDL size and risk of coronary heart disease in elderly men and women

Related Experiment Videos

L Mykkänen1, J Kuusisto, S M Haffner

  • 1Division of Clinical Epidemiology, Department of Medicine, University of Texas Health Science Center at San Antonio, USA.

Insights

Small, dense low density lipoprotein (LDL) particle size does not predict coronary heart disease (CHD) in elderly individuals. Other factors like smoking and high blood pressure are more significant risk factors in this age group.

Area of Science:

  • Cardiology
  • Gerontology
  • Metabolic Syndrome

Background:

  • Small, dense low density lipoprotein (LDL) particles are linked to coronary heart disease (CHD) in younger populations.
  • Previous studies suggest decreased LDL size predicts CHD in middle-aged individuals.
  • The role of LDL size in CHD risk for older adults remains unclear.

Purpose of the Study:

  • To investigate whether decreased LDL particle size predicts coronary heart disease (CHD) events in elderly individuals aged 65-74 years.
  • To compare LDL particle size between elderly subjects who experienced CHD events and those who did not.
  • To identify other predictors of CHD in this elderly cohort.

Main Methods:

  • A prospective, nested case-control study was conducted.
  • 86 elderly cases with myocardial infarction or CHD death and 172 matched controls free of CHD were analyzed.
  • LDL particle size was measured using gradient gel electrophoresis.

Main Results:

  • No significant difference in LDL particle size or LDL subclass phenotype B was found between cases and controls.
  • Factors like smoking, increased systolic blood pressure, apolipoprotein B, and total cholesterol/high density lipoprotein cholesterol ratio were significant CHD predictors.
  • LDL size was not associated with CHD risk in elderly white subjects after adjusting for diabetes status.

Conclusions:

  • Decreased LDL particle size is not a predictor of coronary heart disease (CHD) events in elderly white individuals.
  • Traditional risk factors such as smoking and elevated blood pressure remain significant predictors of CHD in older adults.
  • The predictive value of LDL size for CHD may diminish with age.

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...